The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

 
Web www.patentalert.com

< Method for preparation of ethylene and propylene by catalytic cracking using a fluid-bed catalyst

> Water-dispersible and multicomponent fibers from sulfopolyesters

> Electrochemical energy storage device
~ 00593